VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,232,000 | -54.3% | 59,300 | -68.5% | 0.01% | -57.1% |
| Q3 2017 | $2,694,000 | +96.9% | 187,984 | +137.8% | 0.01% | +75.0% |
| Q2 2017 | $1,368,000 | +15.5% | 79,061 | -26.4% | 0.01% | -20.0% |
| Q1 2017 | $1,184,000 | -57.8% | 107,391 | -44.4% | 0.01% | -50.0% |
| Q4 2016 | $2,803,000 | -40.9% | 193,015 | -0.1% | 0.02% | -42.9% |
| Q3 2016 | $4,744,000 | -21.1% | 193,254 | -35.2% | 0.04% | -23.9% |
| Q2 2016 | $6,011,000 | -35.0% | 298,449 | -15.1% | 0.05% | -38.7% |
| Q1 2016 | $9,247,000 | -85.8% | 351,615 | -45.1% | 0.08% | -65.9% |
| Q4 2015 | $65,127,000 | -45.7% | 640,700 | -4.8% | 0.22% | -65.1% |
| Q3 2015 | $120,049,000 | +60.3% | 673,000 | +99.6% | 0.63% | +41.3% |
| Q2 2015 | $74,886,000 | +20.7% | 337,100 | +7.9% | 0.45% | -5.7% |
| Q1 2015 | $62,049,000 | +37.9% | 312,400 | -0.6% | 0.47% | +39.5% |
| Q4 2014 | $44,980,000 | +321.6% | 314,300 | +286.5% | 0.34% | +313.4% |
| Q3 2014 | $10,669,000 | -60.7% | 81,318 | -62.2% | 0.08% | -68.3% |
| Q2 2014 | $27,139,000 | -14.6% | 215,187 | -10.7% | 0.26% | -4.8% |
| Q1 2014 | $31,767,000 | +8.4% | 240,970 | -3.4% | 0.27% | +33.3% |
| Q4 2013 | $29,299,000 | -7.9% | 249,563 | -18.2% | 0.20% | +209.1% |
| Q3 2013 | $31,816,000 | +79.8% | 304,952 | +48.4% | 0.07% | -1.5% |
| Q2 2013 | $17,695,000 | – | 205,561 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |